• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Biopsy Devices Market Analysis

    ID: MRFR/MED/1652-CR
    80 Pages
    Rahul Gotadki
    March 2023

    Biopsy Devices Market Research Report Information By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles [Vacuum-Assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices, Core Needle Biopsy (CNB) Devices], Biopsy Forceps, Localization Wires, and Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, and Others),...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Biopsy Devices Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Analysis

    In-depth Analysis of Biopsy Devices Market Industry Landscape

    The biopsy devices market is seeing unique development, fundamentally determined by the raising worldwide frequency of cancer. As cancer analyze keep on rising, the interest for biopsy strategies and devices for precise tissue examining becomes principal, positioning the market as an essential player in the oncology diagnostics scene. The market is affected by the pervasiveness of constant illnesses, historical cancer, including immune system problems and persitent sicknesses. Biopsy devices are progressively utilized for obtaining tissue tests for diagnosing and checking different non-cancerous conditions, widening the market's extension past oncology. With a universally maturing populace, there is a characteristic expansion in the incidence of age-related illnesses, including cancer. The biopsy devices market is answering this segment shift by giving arrangements that take care of the demonstrative requirements of old patients, further filling market extension. There is a remarkable pattern in the market elements towards patient inclination for minimally obtrusive biopsy methods. Biopsy devices that offer less pain, reduced recuperation times, and insignificant scarring are gaining occurrence, driving makers to focus in on creating and working on such advancements. Liquid biopsy is arising as a groundbreaking innovation inside the market. The capacity to recognize genetic material and biomarkers in body liquids offers a harmless option in contrast to customary tissue biopsies. This growing application is affecting market elements by giving clinicians extra symptomatic instruments and choices. The coordination of Artificial Intelligence (AI) in biopsy examination is reshaping market elements. AI calculations are being utilized to dissect biopsy tests, aiding pathologists in quicker and more precise analyses. This pattern improves analytic abilities as well as positions the market at the very front of the advanced medical care revolution. The continuous improvement of worldwide medical services framework assumes a part in market elements. As medical services frameworks improve and turn out to be more open, the interest for cutting edge indicative apparatuses, including biopsy devices, increments. This pattern is especially obvious in developing markets where medical care framework is quickly advancing.

    Market Summary

    As per MRFR analysis, the Biopsy Devices Market Size was estimated at 2.81 USD Billion in 2024. The Biopsy Devices industry is projected to grow from 2.971 USD Billion in 2025 to 5.182 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.72 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Biopsy Devices Market is experiencing robust growth driven by technological advancements and increasing demand for minimally invasive procedures.

    • Technological advancements are enhancing the precision and efficiency of biopsy devices, particularly in North America.
    • The rising demand for minimally invasive procedures is propelling the adoption of biopsy guns, which remain the largest segment in the market.
    • In Asia-Pacific, the focus on early detection is driving growth in the biopsy guidance system segment, which is currently the fastest-growing.
    • Key market drivers include the increasing incidence of cancer and the growing geriatric population, both of which are fueling demand for effective biopsy solutions.

    Market Size & Forecast

    2024 Market Size 2.81 (USD Billion)
    2035 Market Size 5.182 (USD Billion)
    CAGR (2025 - 2035) 5.72%
    Largest Regional Market Share in 2024 North America

    Major Players

    <p>Becton Dickinson and Company (US), Boston Scientific Corporation (US), Medtronic plc (IE), Hologic, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), Siemens Healthineers AG (DE), Johnson & Johnson (US), Cook Medical Incorporated (US)</p>

    Market Trends

    The Biopsy Devices Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing emphasis on early disease detection. Innovations in imaging techniques and minimally invasive procedures are enhancing the accuracy and efficiency of biopsies, thereby improving patient outcomes. Furthermore, the growing prevalence of cancer and other chronic diseases is propelling demand for biopsy devices, as healthcare providers seek reliable methods for diagnosis. This market is characterized by a diverse range of products, including needle-based devices, surgical instruments, and imaging-guided systems, each contributing to the overall growth and evolution of the sector. In addition to technological advancements, regulatory support and increased funding for research are likely to play pivotal roles in shaping the Biopsy Devices Market. As healthcare systems worldwide prioritize patient-centered care, the focus on developing user-friendly and efficient biopsy solutions is becoming more pronounced. The integration of artificial intelligence and machine learning into diagnostic processes may further enhance the capabilities of biopsy devices, suggesting a future where precision medicine becomes the norm. Overall, the Biopsy Devices Market appears poised for sustained growth, driven by innovation and a commitment to improving diagnostic accuracy and patient care.

    Technological Advancements

    The Biopsy Devices Market is witnessing rapid technological advancements that enhance the precision and efficiency of diagnostic procedures. Innovations such as robotic-assisted systems and advanced imaging techniques are streamlining the biopsy process, allowing for more accurate tissue sampling and reduced patient discomfort.

    Rising Demand for Minimally Invasive Procedures

    There is a growing preference for minimally invasive procedures within the Biopsy Devices Market, as patients and healthcare providers alike seek alternatives that reduce recovery time and complications. This trend is likely to drive the development of new devices that prioritize patient safety and comfort.

    Increased Focus on Early Detection

    The emphasis on early disease detection is becoming increasingly prominent in the Biopsy Devices Market. As healthcare systems recognize the importance of timely diagnosis, there is a corresponding rise in the demand for advanced biopsy solutions that facilitate early intervention and improve treatment outcomes.

    <p>The ongoing advancements in biopsy devices indicate a transformative shift towards minimally invasive techniques, enhancing diagnostic accuracy and patient outcomes in the healthcare sector.</p>

    U.S. Food and Drug Administration (FDA)

    Biopsy Devices Market Market Drivers

    Rising Incidence of Cancer

    The alarming rise in cancer incidence is a significant factor driving the Biopsy Devices Market. As cancer remains one of the leading causes of mortality worldwide, the need for effective diagnostic tools is more pressing than ever. Biopsy procedures are essential for confirming cancer diagnoses and determining appropriate treatment plans. Recent data indicates that the global cancer burden is expected to increase, with millions of new cases diagnosed annually. This surge in cancer cases is likely to propel the demand for various biopsy devices, including needle biopsies and surgical biopsies. Consequently, the market is poised for growth, as healthcare providers seek to enhance their diagnostic capabilities in response to this escalating health crisis.

    Growing Geriatric Population

    The aging population is a crucial driver for the Biopsy Devices Market, as older individuals are more susceptible to various health conditions, including cancer. As the geriatric demographic continues to expand, the demand for diagnostic procedures, including biopsies, is expected to increase correspondingly. This trend is particularly relevant in developed regions, where healthcare systems are adapting to cater to the needs of an aging populace. Market forecasts indicate that the biopsy devices segment catering to geriatric patients will witness substantial growth, driven by the necessity for accurate and timely diagnoses in this vulnerable group. The implications of this demographic shift are profound, suggesting a sustained demand for innovative biopsy solutions.

    Technological Advancements in Biopsy Devices

    The Biopsy Devices Market is experiencing a notable transformation due to rapid technological advancements. Innovations such as automated biopsy systems and imaging-guided techniques are enhancing the precision and efficiency of biopsy procedures. For instance, the integration of artificial intelligence in imaging technologies is facilitating real-time analysis, which may lead to improved diagnostic accuracy. Furthermore, the development of advanced needle technologies, such as core needle and vacuum-assisted biopsy devices, is likely to reduce patient discomfort and recovery time. According to recent data, the market for automated biopsy devices is projected to grow at a compound annual growth rate of approximately 8% over the next five years, indicating a robust demand for these advanced solutions.

    Increased Focus on Early Detection of Diseases

    The Biopsy Devices Market is also being propelled by an increased focus on early detection of diseases, particularly cancer. Early diagnosis is critical for improving patient outcomes, and biopsy procedures play a pivotal role in this process. As healthcare systems worldwide emphasize preventive care, the demand for biopsy devices is likely to surge. Recent statistics indicate that the incidence of various cancers is on the rise, necessitating the need for effective diagnostic tools. Consequently, the market for biopsy devices is projected to expand, with a significant portion of growth attributed to the rising number of screening programs and initiatives aimed at early disease detection.

    Rising Demand for Minimally Invasive Procedures

    The increasing preference for minimally invasive procedures is significantly influencing the Biopsy Devices Market. Patients and healthcare providers alike are gravitating towards techniques that minimize surgical trauma and expedite recovery. This trend is particularly evident in oncology, where early and accurate diagnosis is crucial. As a result, devices that facilitate minimally invasive biopsies, such as fine needle aspiration and endoscopic ultrasound-guided biopsies, are witnessing heightened adoption. Market analysis suggests that the segment of minimally invasive biopsy devices is expected to account for a substantial share of the overall market, driven by the growing awareness of patient-centric care and the benefits of reduced hospitalization.

    Market Segment Insights

    By Type: Biopsy Guns (Largest) vs. Biopsy Guidance System (Fastest-Growing)

    <p>The Biopsy Devices Market segments into Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, Localization Wires, and Others. Among these, Biopsy Guns hold the largest market share due to their efficiency and widespread usage in various procedures. Following this, Biopsy Guidance Systems are emerging rapidly, demonstrating remarkable growth driven by advancements in imaging technologies that enhance precision in targeting lesion sites. As the demand for minimally invasive procedures increases, the growth of Biopsy Guidance Systems is particularly notable. Factors such as the rising prevalence of cancer and the emphasis on early diagnosis are propelling the adoption of advanced biopsy technologies. Additionally, the integration of robotic assistance and augmented reality in biopsy guidance is expected to further boost market expansion, making it a key focus area for investment and development.</p>

    <p>Biopsy Guns (Dominant) vs. Biopsy Needles (Emerging)</p>

    <p>Biopsy Guns are pivotal in the Biopsy Devices Market, offering both speed and accuracy, making them the dominant choice for clinicians. These devices are characterized by their ability to rapidly obtain tissue samples, significantly reducing procedure time while ensuring quality. In contrast, Biopsy Needles, while traditionally viewed as a staple in biopsy procedures, are evolving as an emerging competitor. The development of specialized needles designed for specific types of tissue sampling is enhancing their market appeal. The versatility and adaptability of Biopsy Needles in various diagnostic scenarios position them as essential tools within the market, leading to increased manufacturer focus on innovation for enhanced performance.</p>

    By Application: Breast Biopsy (Largest) vs. Prostate Biopsy (Fastest-Growing)

    <p>The biopsy devices market is diverse, with various applications serving different medical needs. Among these, Breast Biopsy holds the largest market share, largely attributed to the high prevalence of breast cancer and the increasing awareness of early detection. Prostate Biopsy, while holding a smaller portion, has shown remarkable growth potential due to an uptick in prostate cancer diagnoses and advancements in procedural techniques that enhance patient outcomes. This shift is indicative of changing healthcare priorities and diagnostic trends in urology. Notably, growth trends within the Biopsy Devices Market indicate a shift towards minimally invasive procedures across all application segments. However, Prostate Biopsy has emerged as the fastest-growing segment, driven by innovations in imaging technologies and needle biopsy techniques that allow for more accurate diagnoses with less patient discomfort. Furthermore, the increasing aging population and rising cancer incidence rates further fuel the demands for advanced biopsy devices, promoting growth particularly in prostate and liver biopsy procedures.</p>

    <p>Breast Biopsy (Dominant) vs. Lung Biopsy (Emerging)</p>

    <p>Breast Biopsy stands out as the dominant application in the biopsy devices market, primarily due to the prevalent focus on early cancer detection and the successful implementation of screening programs. The sophistication of devices used, including stereotactic and ultrasound-guided techniques, enhances precision and patient safety, cementing its leading position. Conversely, Lung Biopsy is categorized as an emerging application amid rising lung cancer cases and enhanced diagnostic protocols. Newer methods, like navigation bronchoscopy, offer less invasive solutions and higher accuracy for lung tissue sampling. While Breast Biopsy leads in familiarity and routine use, Lung Biopsy's potential is rapidly unfolding as healthcare systems adapt to the growing need for effective lung cancer management, marking a shift in biopsy device utilization towards lung-related applications.</p>

    By Guidance Technique: Ultrasound-Guided Biopsy (Largest) vs. MRI-Guided Biopsy (Fastest-Growing)

    <p>The Guidance Technique segment in the Biopsy Devices Market showcases a diverse array of methodologies, with Ultrasound-Guided Biopsy leading the way as the predominant technique. This method is widely utilized due to its cost-effectiveness and real-time imaging capabilities, capturing a significant market share. Stereotactic Guided Biopsy follows closely, offering precise targeting for lesions, while MRI-Guided Biopsy and CT Guided Biopsy are also notable participants, addressing specific diagnostic needs. Others include emerging techniques that contribute to the innovative landscape of biopsy technologies. In terms of growth trends, MRI-Guided Biopsy is emerging as the fastest-growing segment, driven by advancements in imaging technology and increasing demand for non-invasive procedures. The overall trend is towards enhancing accuracy and reducing the risks associated with traditional biopsies. Factors such as rising cancer incidence, the aging population, and improved healthcare spending are propelling the adoption of these advanced imaging-guided techniques, fostering competition and innovation within the market.</p>

    <p>Ultrasound-Guided Biopsy (Dominant) vs. Stereotactic Guided Biopsy (Emerging)</p>

    <p>Ultrasound-Guided Biopsy is recognized as the dominant force in the Guidance Technique segment, primarily due to its widespread application and effectiveness in various clinical scenarios. This technique offers real-time imaging, allowing for immediate adjustments during the procedure, which enhances accuracy and patient outcomes. Conversely, Stereotactic Guided Biopsy is seen as an emerging technique within this segment. It is particularly advantageous for sampling from deep-seated lesions, leveraging advanced imaging systems for precision. Both techniques are critical in the biopsies landscape, addressing unique clinical needs while driving innovation and enhancing procedural efficacy.</p>

    By End User: Hospitals & Clinics (Largest) vs. Diagnostic & Imaging Centers (Fastest-Growing)

    <p>In the Biopsy Devices Market, Hospitals & Clinics hold the largest share, driven by their extensive use of biopsy procedures for diagnosing various conditions. This segment benefits from the high patient footfall and advanced medical technology adoption in healthcare facilities. On the other hand, Diagnostic & Imaging Centers are emerging as a significant player, utilizing cutting-edge imaging techniques to enhance the precision of biopsy processes, thus steadily capturing a larger market share.</p>

    <p>Hospitals & Clinics (Dominant) vs. Diagnostic & Imaging Centers (Emerging)</p>

    <p>Hospitals & Clinics represent the dominant end-user segment in the Biopsy Devices Market, leveraging their robust infrastructure and specialized personnel to conduct a vast number of biopsy procedures. They utilize a wide range of biopsy devices, including needle biopsies and core biopsies, ensuring comprehensive patient care. In contrast, Diagnostic & Imaging Centers are swiftly emerging, capitalizing on technological advancements such as MRI and CT imaging to improve diagnostic accuracy. Their focus on non-invasive biopsy methods appeals to patients seeking less discomfort, contributing to their rapid growth as a preferred option for diagnostic services in the healthcare landscape.</p>

    Get more detailed insights about Biopsy Devices Market Research Report - Global Forecast to 2035

    Regional Insights

    North America : Market Leader in Innovation

    North America is the largest market for biopsy devices, holding approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cancer, and rising demand for minimally invasive procedures. Regulatory support from agencies like the FDA further catalyzes innovation and market expansion, ensuring that new technologies are swiftly integrated into clinical practice. The United States is the primary contributor to this market, with key players such as Becton Dickinson and Company, Boston Scientific Corporation, and Hologic, Inc. leading the competitive landscape. The presence of established healthcare systems and significant investments in research and development bolster the market. Additionally, the focus on early diagnosis and personalized medicine enhances the demand for advanced biopsy devices, solidifying North America's position as a market leader.

    Europe : Emerging Market with Growth Potential

    Europe is witnessing significant growth in the biopsy devices market, accounting for approximately 30% of the global share. The region benefits from a robust healthcare system, increasing awareness of early cancer detection, and supportive regulatory frameworks. The European Medicines Agency (EMA) plays a crucial role in ensuring the safety and efficacy of medical devices, which fosters innovation and market growth. Leading countries in this region include Germany, France, and the UK, where major players like Siemens Healthineers AG and Medtronic plc are actively involved. The competitive landscape is characterized by a mix of established companies and emerging startups, focusing on technological advancements and patient-centric solutions. The increasing incidence of cancer and the demand for precise diagnostic tools are driving the adoption of biopsy devices across Europe.

    Asia-Pacific : Rapidly Growing Healthcare Sector

    Asia-Pacific is emerging as a significant player in the biopsy devices market, holding around 20% of the global share. The region's growth is fueled by rising healthcare expenditures, increasing awareness of cancer screening, and advancements in medical technology. Countries like China and India are witnessing rapid improvements in healthcare infrastructure, which is expected to further boost market demand for biopsy devices. China is the largest market in this region, with a growing number of healthcare facilities and a rising population of cancer patients. The competitive landscape includes both local manufacturers and international players, such as Abbott Laboratories and Thermo Fisher Scientific Inc. The focus on improving diagnostic accuracy and patient outcomes is driving innovation in biopsy technologies, making Asia-Pacific a key region for future growth.

    Middle East and Africa : Untapped Market with Opportunities

    The Middle East and Africa (MEA) region is gradually emerging in the biopsy devices market, currently holding about 5% of the global share. The growth is primarily driven by increasing healthcare investments, rising awareness of cancer prevalence, and the need for advanced diagnostic tools. Governments in the region are implementing initiatives to improve healthcare access, which is expected to enhance market dynamics in the coming years. Countries like South Africa and the UAE are leading the market, with a growing number of healthcare facilities and increasing demand for innovative medical technologies. The competitive landscape is evolving, with both local and international companies vying for market share. The focus on improving healthcare outcomes and expanding access to diagnostic services presents significant opportunities for growth in the biopsy devices market in MEA.

    Key Players and Competitive Insights

    The Biopsy Devices is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cancer. Key players such as Becton Dickinson and Company (US), Hologic, Inc. (US), and Medtronic plc (IE) are strategically positioned to leverage innovation and expand their market presence. Becton Dickinson and Company (US) focuses on enhancing its product portfolio through continuous research and development, while Hologic, Inc. (US) emphasizes its commitment to women's health, particularly in breast biopsy technologies. Medtronic plc (IE) appears to be concentrating on integrating digital solutions into its biopsy devices, thereby enhancing diagnostic accuracy and patient outcomes. Collectively, these strategies foster a competitive environment that prioritizes innovation and patient-centric solutions.

    In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The Biopsy Devices Market is moderately fragmented, with several players vying for market share. This fragmentation allows for diverse offerings, yet the influence of key players remains substantial, as they set benchmarks for quality and technological advancement. The collective actions of these companies shape a competitive structure that encourages ongoing innovation and responsiveness to market demands.

    In August 2025, Hologic, Inc. (US) announced the launch of its latest biopsy device, which incorporates AI-driven imaging technology to enhance precision in tissue sampling. This strategic move not only positions Hologic as a leader in technological integration but also addresses the growing demand for accurate diagnostics in oncology. The introduction of AI capabilities is likely to attract healthcare providers seeking to improve patient outcomes through advanced diagnostic tools.

    In September 2025, Medtronic plc (IE) revealed a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its biopsy devices. This collaboration aims to streamline the biopsy process and facilitate real-time data sharing between patients and healthcare professionals. By embracing telehealth, Medtronic is not only enhancing patient engagement but also adapting to the evolving healthcare landscape, which increasingly favors remote solutions.

    In July 2025, Becton Dickinson and Company (US) expanded its manufacturing facility in the United States to increase production capacity for its biopsy devices. This expansion reflects the company's commitment to meeting rising global demand and underscores its strategy of localizing production to enhance supply chain reliability. Such initiatives are crucial in a market where timely access to innovative devices can significantly impact patient care.

    As of October 2025, the Biopsy Devices Market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming increasingly prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, quality, and supply chain resilience, suggesting a future where innovation and reliability are paramount.

    Key Companies in the Biopsy Devices Market market include

    Industry Developments

    • Q2 2024: BD Launches New UltraCore™ Single-Use Biopsy Device for Improved Patient Safety Becton, Dickinson and Company (BD) announced the launch of its UltraCore™ single-use biopsy device, designed to enhance procedural safety and reduce infection risk in tissue sampling procedures.
    • Q2 2024: Hologic Receives FDA Clearance for Brevera® Breast Biopsy System with CorLumina® Imaging Technology Hologic, Inc. received FDA clearance for its Brevera® Breast Biopsy System with CorLumina® Imaging Technology, enabling real-time imaging and improved workflow for breast tissue sampling.
    • Q2 2024: Argon Medical Devices Announces Launch of SuperCore™ Advantage Biopsy Instrument Argon Medical Devices launched the SuperCore™ Advantage Biopsy Instrument, a new device designed to provide enhanced tissue yield and ease of use for clinicians performing soft tissue biopsies.
    • Q2 2024: Merit Medical Launches Temno Evolution Biopsy Device with Single-Use Design Merit Medical Systems, Inc. introduced the Temno Evolution Biopsy Device, featuring a single-use, ergonomically contoured body to improve procedural safety and reduce the risk of cross-contamination.
    • Q3 2024: INRAD, Inc. Announces FDA 510(k) Clearance for New MRI-Guided Biopsy Needle INRAD, Inc. received FDA 510(k) clearance for its new MRI-guided biopsy needle, expanding its portfolio of minimally invasive diagnostic tools for soft tissue sampling.
    • Q3 2024: Siemens Healthineers and BioVentrix Announce Strategic Partnership to Advance Image-Guided Biopsy Solutions Siemens Healthineers and BioVentrix entered a strategic partnership to co-develop advanced image-guided biopsy solutions, aiming to improve diagnostic accuracy and patient outcomes.
    • Q3 2024: Boston Scientific Appoints New President of Interventional Oncology and Biopsy Devices Division Boston Scientific Corporation announced the appointment of a new president to lead its Interventional Oncology and Biopsy Devices Division, signaling a renewed focus on innovation and market expansion.
    • Q4 2024: MDxHealth Announces CE Mark for SelectMDx Prostate Biopsy Device in Europe MDxHealth received CE Mark approval for its SelectMDx Prostate Biopsy Device, allowing commercialization and clinical use across the European Union.
    • Q4 2024: Cook Medical Opens New Biopsy Device Manufacturing Facility in Indiana Cook Medical opened a new manufacturing facility in Indiana dedicated to the production of biopsy devices, aiming to meet growing demand and improve supply chain resilience.
    • Q1 2025: Veracyte Announces $50 Million Series D Funding to Expand Biopsy Diagnostics Portfolio Veracyte, Inc. raised $50 million in Series D funding to accelerate the development and commercialization of its biopsy diagnostics portfolio, including new minimally invasive tissue sampling technologies.
    • Q1 2025: Roche Receives FDA Approval for NAVIFY® Biopsy Workflow Solution Roche announced FDA approval for its NAVIFY® Biopsy Workflow Solution, a digital platform designed to streamline and standardize the biopsy process in clinical settings.
    • Q2 2025: BD Acquires BiopsyTech, Expanding Portfolio of Minimally Invasive Biopsy Devices Becton, Dickinson and Company (BD) completed the acquisition of BiopsyTech, a company specializing in minimally invasive biopsy devices, to strengthen its position in the global biopsy devices market.

    Future Outlook

    Biopsy Devices Market Future Outlook

    <p>The Biopsy Devices Market is projected to grow at a 5.72% CAGR from 2024 to 2035, driven by technological advancements, increasing cancer prevalence, and rising demand for minimally invasive procedures.</p>

    New opportunities lie in:

    • <p>Development of AI-integrated biopsy systems for enhanced diagnostic accuracy.</p>
    • <p>Expansion of telehealth services for remote biopsy consultations.</p>
    • <p>Investment in biodegradable biopsy devices to meet sustainability goals.</p>

    <p>By 2035, the Biopsy Devices Market is expected to achieve substantial growth, driven by innovation and evolving healthcare needs.</p>

    Market Segmentation

    Biopsy Devices Market Type Outlook

    • Biopsy Guns
    • Biopsy Guidance System
    • Biopsy Needles
    • Biopsy Forceps
    • Localization Wires
    • Others

    Biopsy Devices Market End User Outlook

    • Hospitals & Clinics
    • Diagnostic & Imaging Centers
    • Academic & Research Institutes
    • Others

    Biopsy Devices Market Application Outlook

    • Breast Biopsy
    • Prostate Biopsy
    • Liver Biopsy
    • Lung Biopsy
    • Gynecological Biopsy
    • Others

    Biopsy Devices Market Guidance Technique Outlook

    • Ultrasound-Guided Biopsy
    • Stereotactic Guided Biopsy
    • MRI-Guided Biopsy
    • CT Guided Biopsy
    • Others

    Report Scope

    MARKET SIZE 20242.81(USD Billion)
    MARKET SIZE 20252.971(USD Billion)
    MARKET SIZE 20355.182(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)5.72% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesAdvancements in minimally invasive techniques enhance growth potential in the Biopsy Devices Market.
    Key Market DynamicsTechnological advancements and regulatory changes drive innovation and competition in the biopsy devices market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected market valuation of the Biopsy Devices Market by 2035?

    The Biopsy Devices Market is projected to reach a valuation of 5.182 USD Billion by 2035.

    What was the market valuation of the Biopsy Devices Market in 2024?

    In 2024, the overall market valuation was 2.81 USD Billion.

    What is the expected CAGR for the Biopsy Devices Market during the forecast period 2025 - 2035?

    The expected CAGR for the Biopsy Devices Market during the forecast period 2025 - 2035 is 5.72%.

    Which segment of biopsy devices is projected to have the highest growth by 2035?

    Biopsy Guns are projected to grow from 0.84 USD Billion in 2024 to 1.56 USD Billion by 2035.

    How do the revenues of breast biopsy devices compare to prostate biopsy devices in 2024?

    In 2024, breast biopsy devices generated 0.84 USD Billion, while prostate biopsy devices accounted for 0.68 USD Billion.

    1. Introduction
      1. Definition
      2. Scope of Study
      3. Research Objective
      4. Assumptions & Limitations
      5. Market Structure:
    2. Research Methodology
      1. Research Process
      2. Primary Research
      3. Secondary Research
    3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
    4. Market Factor Analysis
      1. Porter’s five forces model
        1. Bargaining Power of suppliers
        2. Bargaining Power of Customer
        3. Intensity of Competitor’s
        4. Threat of New Entrants
    5. Global Biopsy Devices Market, by Product Type
      1. Introduction
        1. Biopsy Guns
        2. Biopsy Guidance System
        3. Biopsy Needles
        4. Biopsy Forceps
        5. Others
    6. Global Biopsy Devices Market, by Application
      1. Introduction
        1. Surgical biopsy
        2. Skin biopsy
        3. Needle biopsy
        4. Bone marrow biopsy
        5. Cancer Diagnosis
        6. Others
    7. Global Biopsy Devices Market, by End User
      1. Introduction
        1. Hospitals
        2. Specialty Clinics
        3. Diagnostic centers Academic & Research Institutes
        4. Academic & Research Institutes
        5. Others
    8. Global Biopsy Devices Market, by Regions
      1. Introduction
        1. Americas
        2. Europe
        3. Asia Pacific
        4. Middle East & Africa
    9. Company Landscape
      1. Introduction
        1. Mergers Acquisitions
        2. Collaborations
        3. Release/New Product Launches
        4. Other (Expansion, Updates, Partnership)
    10. Company Profile
      1. Argon Medical Devices, Inc.
        1. Company Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      2. BD
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      3. Cook Medical
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      4. C. R. Bard, Inc.
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      5. Creganna
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      6. Focal Therapeutics, Inc.
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      7. Hologic, Inc.
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      8. Integra LifeSciences Corporation
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      9. Leica Biosystems
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      10. Precision Biopsy, LLC
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      11. Scion Medical Technologies, LLC.
        1. Overview
        2. Product/Business Segment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      12. Others
    11. Appendix
      1. List of Tables
    12. GLOBAL BIOPSY DEVICES MARKET, 2020-2027 (USD MILLION)
    13. GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)
    14. GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    15. GLOBAL BIOPSY DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    16. GLOBAL BIOPSY DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
      1. List of Figures
    17. RESEARCH PROCESS
    18. PORTERS FIVE FORCES MODEL
    19. GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE
    20. GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION
    21. GLOBAL BIOPSY DEVICES MARKET, BY END USER
    22. GLOBAL BIOPSY DEVICES MARKET, BY REGION
    23. GLOBAL BIOPSY DEVICES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
      1. "

     

    Global Biopsy Devices Market Segmentation

    Biopsy Devices Product Type Outlook (USD Billion, 2019-2030)

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Biopsy Devices Application Outlook (USD Billion, 2019-2030)

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Biopsy Devices Guidance Outlook (USD Billion, 2019-2030)

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Biopsy Devices End User Outlook (USD Billion, 2019-2030)

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Biopsy Devices Regional Outlook (USD Billion, 2019-2030)

    North America Outlook (USD Billion, 2019-2030)

    North America Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    North America Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    North America Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    North America Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    US Outlook (USD Billion, 2019-2030)

    US Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    US Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    US Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    US Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Canada Outlook (USD Billion, 2019-2030)

    Canada Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Canada Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Canada Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Canada Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Europe Outlook (USD Billion, 2019-2030)

    Europe Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Europe Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Europe Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Europe Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Germany Outlook (USD Billion, 2019-2030)

    Germany Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Germany Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Germany Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Germany Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    France Outlook (USD Billion, 2019-2030)

    France Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    France Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    France Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    France Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    UK Outlook (USD Billion, 2019-2030)

    UK Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    UK Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    UK Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    UK Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Italy Outlook (USD Billion, 2019-2030)

    Italy Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Italy Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Italy Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Italy Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Spain Outlook (USD Billion, 2019-2030)

    Spain Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Spain Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Spain Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Spain Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Rest Of Europe Outlook (USD Billion, 2019-2030)

    Rest of Europe Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Rest of Europe Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Rest of Europe Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Rest of Europe Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Asia-Pacific Outlook (USD Billion, 2019-2030)

    Asia-Pacific Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Asia-Pacific Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Asia-Pacific Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Asia-Pacific Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    China Outlook (USD Billion, 2019-2030)

    China Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    China Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    China Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    China Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Japan Outlook (USD Billion, 2019-2030)

    Japan Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Japan Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Japan Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Japan Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    India Outlook (USD Billion, 2019-2030)

    India Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    India Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    India Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    India Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    South Korea Outlook (USD Billion, 2019-2030)

    South Korea Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    South Korea Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    South Korea Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    South Korea Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Australia Outlook (USD Billion, 2019-2030)

    Australia Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Australia Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Australia Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Australia Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

    Rest of Asia-Pacific Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Rest of Asia-Pacific Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Rest of Asia-Pacific Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Rest of Asia-Pacific Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Rest of the World Outlook (USD Billion, 2019-2030)

    Rest of the World Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Rest of the World Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Rest of the World Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Rest of the World Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Middle East Outlook (USD Billion, 2019-2030)

    Middle East Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Middle East Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Middle East Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Middle East Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Africa Outlook (USD Billion, 2019-2030)

    Africa Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Africa Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Africa Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Africa Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

    Latin America Outlook (USD Billion, 2019-2030)

    Latin America Biopsy Devices by Product Type

    Biopsy Guns

    Biopsy Guidance System

    Biopsy Needles

    Vacuum-Assisted Biopsy (VAB) Devices

    Fine Needle Aspiration Biopsy (FNAB) Devices

    Core Needle Biopsy (CNB) Devices

    Biopsy Forceps

    Localization Wires

    Others

    Latin America Biopsy Devices by Application

    Breast Biopsy

    Prostate Biopsy

    Liver Biopsy

    Lung Biopsy

    Gynecological Biopsy

    Others

    Latin America Biopsy Devices by Guidance Technique

    Ultrasound-Guided Biopsy

    Stereotactic Guided Biopsy

    MRI-Guided Biopsy

    CT Guided Biopsy

    Others

    Latin America Biopsy Devices by End User

    Hospitals & Clinics

    Diagnostic & Imaging Centers

    Academic & Research Institutes

    Others

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027